| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 746930 | Null | 0.0126882509540132 | 0.060340518 |
| NSC 87221 | Actinomycin D, 2A-D-alloisoleucine- (9CI) | 0.0126882509540132 | 0.11375861 |
| NSC 89671 | Ascotoxin | 0.0126882509540132 | -0.305391 |
| NSC 105014 | Cladribine | 0.0126882509540134 | 0.42253016 |
| NSC 129794 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) | 0.0126882509540134 | 0.0037443912 |
| NSC 163424 | 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- | 0.0126882509540134 | 0.45789685 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0126882509540134 | 0.24391736 |
| NSC 328410 | Camptothecin Derivative | 0.0126882509540134 | 0.51275705 |
| NSC 33570 | Null | 0.0126882509540134 | 0.41151507 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0126882509540134 | 0.36212432 |